Pathological angiogenesis: mechanisms and therapeutic strategies

AC Dudley, AW Griffioen - Angiogenesis, 2023 - Springer
In multicellular organisms, angiogenesis, the formation of new blood vessels from pre-
existing ones, is an essential process for growth and development. Different mechanisms …

Anti-angiogenic agents—overcoming tumour endothelial cell anergy and improving immunotherapy outcomes

ZR Huinen, EJM Huijbers, JR van Beijnum… - Nature Reviews …, 2021 - nature.com
Immune checkpoint inhibitors have revolutionized medical oncology, although currently only
a subset of patients has a response to such treatment. A compelling body of evidence …

Vessel co-option in cancer

EA Kuczynski, PB Vermeulen, F Pezzella… - Nature reviews Clinical …, 2019 - nature.com
All solid tumours require a vascular supply in order to progress. Although the ability to
induce angiogenesis (new blood vessel growth) has long been regarded as essential to this …

The anti-VEGF (R) drug discovery legacy: improving attrition rates by breaking the vicious cycle of angiogenesis in cancer

D Ribatti, AG Solimando, F Pezzella - Cancers, 2021 - mdpi.com
Simple Summary Several anti-angiogenic drugs have been approved for cancer treatment,
alone or in combination with other anti-tumoral agents. Angiogenesis inhibitors cause drug …

Key issues in conducting a meta-analysis of gene expression microarray datasets

A Ramasamy, A Mondry, CC Holmes… - PLoS medicine, 2008 - journals.plos.org
Key Issues in Conducting a Meta-Analysis of Gene Expression Microarray Datasets | PLOS
Medicine Skip to main content Advertisement PLOS Medicine Browse Current Issue Journal …

Vessel co‐option in primary human tumors and metastases: an obstacle to effective anti‐angiogenic treatment?

T Donnem, J Hu, M Ferguson, O Adighibe… - Cancer …, 2013 - Wiley Online Library
Angiogenesis has been regarded as essential for tumor growth and progression. Studies of
many human tumors, however, suggest that their microcirculation may be provided by …

Tumor angiogenesis revisited: regulators and clinical implications

R Ronca, M Benkheil, S Mitola, S Struyf… - Medicinal research …, 2017 - Wiley Online Library
Abstract Since Judah Folkman hypothesized in 1971 that angiogenesis is required for solid
tumor growth, numerous studies have been conducted to unravel the angiogenesis process …

Probabilistic embedding, clustering, and alignment for integrating spatial transcriptomics data with PRECAST

W Liu, X Liao, Z Luo, Y Yang, MC Lau, Y Jiao… - Nature …, 2023 - nature.com
Spatially resolved transcriptomics involves a set of emerging technologies that enable the
transcriptomic profiling of tissues with the physical location of expressions. Although a …

Non-angiogenic tumours and their influence on cancer biology

T Donnem, AR Reynolds, EA Kuczynski… - Nature Reviews …, 2018 - nature.com
Solid tumours need a blood supply, and a large body of evidence has previously suggested
that they can grow only if they induce the development of new blood vessels, a process …

Tumors resurrect an embryonic vascular program to escape immunity

EJM Huijbers, KA Khan, RS Kerbel, AW Griffioen - Science immunology, 2022 - science.org
Tumors can escape immunity through multiple mechanisms, one of which is by enforcing a
state of unresponsiveness of the tumor vasculature to inflammatory cytokines. This results in …